Regal Partners Ltd Makes New Investment in Inspire Medical Systems, Inc. $INSP

Regal Partners Ltd acquired a new stake in Inspire Medical Systems, Inc. (NYSE:INSP) in the 3rd quarter, according to its most recent disclosure with the SEC. The fund acquired 101,714 shares of the company’s stock, valued at approximately $7,547,000. Inspire Medical Systems makes up about 0.5% of Regal Partners Ltd’s portfolio, making the stock its 26th largest holding.

A number of other institutional investors have also recently modified their holdings of the stock. Texas Permanent School Fund Corp grew its holdings in shares of Inspire Medical Systems by 42.2% during the 2nd quarter. Texas Permanent School Fund Corp now owns 40,042 shares of the company’s stock worth $5,196,000 after purchasing an additional 11,892 shares in the last quarter. Y Intercept Hong Kong Ltd raised its stake in Inspire Medical Systems by 553.1% in the third quarter. Y Intercept Hong Kong Ltd now owns 99,049 shares of the company’s stock valued at $7,349,000 after purchasing an additional 83,883 shares in the last quarter. CW Advisors LLC raised its stake in Inspire Medical Systems by 45.3% in the second quarter. CW Advisors LLC now owns 49,960 shares of the company’s stock valued at $6,484,000 after purchasing an additional 15,576 shares in the last quarter. Capital Fund Management S.A. lifted its position in Inspire Medical Systems by 44.1% during the second quarter. Capital Fund Management S.A. now owns 68,663 shares of the company’s stock worth $8,910,000 after purchasing an additional 21,021 shares during the period. Finally, Norges Bank bought a new stake in Inspire Medical Systems during the second quarter worth about $31,066,000. 94.91% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities analysts have commented on the stock. Truist Financial decreased their target price on shares of Inspire Medical Systems from $96.00 to $70.00 and set a “hold” rating on the stock in a report on Thursday, February 12th. Wolfe Research downgraded shares of Inspire Medical Systems from an “outperform” rating to a “peer perform” rating in a report on Friday, February 13th. Stifel Nicolaus reduced their price target on shares of Inspire Medical Systems from $95.00 to $85.00 and set a “buy” rating on the stock in a research report on Thursday. Jefferies Financial Group decreased their price objective on shares of Inspire Medical Systems from $81.00 to $66.00 and set a “hold” rating on the stock in a research note on Thursday, February 12th. Finally, Piper Sandler lowered their price objective on shares of Inspire Medical Systems from $165.00 to $85.00 and set an “overweight” rating for the company in a research report on Thursday, February 12th. Five investment analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $104.24.

Inspire Medical Systems Stock Up 0.9%

Inspire Medical Systems stock opened at $63.01 on Friday. The stock has a market cap of $1.80 billion, a PE ratio of 12.65, a P/E/G ratio of 3.09 and a beta of 0.74. Inspire Medical Systems, Inc. has a 12-month low of $53.11 and a 12-month high of $189.49. The business’s 50-day moving average price is $77.16 and its two-hundred day moving average price is $87.18.

Inspire Medical Systems (NYSE:INSP) last posted its earnings results on Wednesday, February 11th. The company reported $1.65 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.96. Inspire Medical Systems had a net margin of 15.95% and a return on equity of 10.96%. The firm had revenue of $269.08 million during the quarter, compared to analysts’ expectations of $264.02 million. During the same quarter in the prior year, the business earned $1.15 earnings per share. The business’s revenue for the quarter was up 12.2% compared to the same quarter last year. As a group, analysts expect that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current year.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.